8:20 am - 8:29 am:  Update on Faricimab for AMD and DME.  Michael Ip, MD

8:29 am - 8:38 am:  Oral Plasma Kallikrein Inhibitor for Patients with DME: Phase 2 Study Design and Patient Characteristics.  Robert B. Bhisitkul, MD, PhD

8:38 am - 8:47 am:  Should I Switch All Patients on Aflibercept 2mg to Aflibercept 8mg?  Diana V. Do, MD, FASRS

8:47 am – 8:56 am:  The Potential Role of BCVA in Home Monitoring and Treat and Extend Protocols for Patients with DME.  Yasir J. Sepah, MBBS

8:56 am – 9:05 am:  What is New In-Home OCT and Monitoring?  Christopher Or, MD

9:05 am – 9:14 am:  Updates from the LIGHT III Study.  Diana V. Do, MD, FASRS

8:56 am – 9:05 am:  Outcomes of Primary Vitrectomy for RRD: Interventional Retrospective Consecutive Case Series of 116 Patients with No Positioning.  David Almeida, MD, MBA, PhD, FASRS

9:10 am – 9:30 am:  Panel Discussion